The custom antibody market in Europe is expected to grow from US$ 102.5 million in 2021 to US$ 213.7 million by 2028; it is estimated to grow at a CAGR of 11.1% from 2021 to 2028. Biotechnology companies have been prominently focusing on collaborations, partnerships, acquisitions, and financial aids or funding for making progress in the markets they serve. Moreover, the COVID-19 pandemic has served opportunities to players to make some important strategic decisions. Following are a few instances of market consolidations that has leveraged growth of custom antibodies market. In January 2021, Morphic Therapeutic, a biotechnology company, collaborated with Janssen Pharmaceutical, Inc., a part of Johnson & Johnson Private Limited, to develop novel antibodies against third integrin target proteins (a family of ubiquitous receptors). Moreover, in July 2020, Cancer Research UK collaborated with Abcam, a life science reagents and tools developer, for the development of custom antibodies to enhance of cancer research and commercialize novel therapies. In January 2020, Abcam acquired Applied StemCell’s gene editing platform and oncology product portfolio, with an aim to strengthen its validation initiative for antibody quality control.
Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. Several companies have experienced severe losses in the last quarter of 2019; they have also negatively influenced the first and second quarters of 2020. Hence, the impact of COVID 19 on the European market was immediate and drastic. The custom antibody supply chain, which is already logistically complicated, has to face new challenges. The custom antibody market has also witnessed some shortfall at the beginning of the COVID 19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. This result may last till the end of 2020 as most of the market players in Europe yet to adopt the novel diagnostic tests for COVID 19. However, in the extended period, the requirement for custom antibodies is expected to increase due to supportive government initiatives. For instance, in May 2020, ProteoGenix launched the first Human Immune COVID-19 library for the fast development of potent antibodies against SARS-CoV-2. Hence, the European custom antibody market will likely show significant growth prospects during this pandemic and forecasted year. Therefore, the preference for adopting custom antibody provides a favorable environment for the growth of the Europe custom antibody market during the forecast period.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the custom antibody market. The Europe Custom antibody market is expected to grow at a good CAGR during the forecast period.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Europe Custom Antibody Market Segmentation
By Service
- Antibody Development
- Antibody Production and Purification
- Antibody Fragmentation and Labelling
By Type
- Monoclonal Antibodies
- Polyclonal Antibodies
- Other Custom Antibodies
By Source
- Mice
- Rabbits
- Others
By Research Area
- Oncology
- Immunology
- Stem Cells
- Infectious Diseases
- Neurobiology
- Cardiovascular Diseases
- Others
By End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
By Country
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Companies Mentioned
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Agilent Technologies, Inc.
- Cell Signaling Technology, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Service, Type, Source, Research Area, End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Custom Antibody Market – By Service
1.3.2 Custom Antibody Market – By Type
1.3.3 Custom Antibody Market – By Source
1.3.4 Custom Antibody Market – By Research Area
1.3.5 Custom Antibody Market – By End User
1.3.6 Europe Custom Antibody Market – By Country
2. Europe Custom Antibody Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Custom Antibody Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Custom Antibody Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Custom Antibody Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 High Demand in Research
5.1.2 Market Consolidations Strategies Adopted by Biotechnology Companies
5.1.3 Production and Development Services Offered by Custom Antibody Providers
5.2 Market Restraints
5.2.1 High Cost of Production
5.3 Future Trends
5.3.1 Developments for Custom Antibodies
5.4 Impact Analysis
6. Custom Antibody Market – Europe Analysis
6.1 Europe Custom Antibody Market Revenue Forecasts and Analysis
7. Europe Custom Antibody Market Analysis and Forecasts To 2028 – By Service
7.1 Overview
7.2 Custom Antibody Market Revenue Share, by Service (2020 and 2028)
7.3 Antibody Development
7.3.1 Overview
7.3.2 Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Antibody Production and Purification
7.4.1 Overview
7.4.2 Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Antibody Fragmentation and Labelling
7.5.1 Overview
7.5.2 Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8. Europe Custom Antibody Market Analysis and Forecasts To 2028 – By Type
8.1 Overview
8.2 Custom Antibody Market Revenue Share, by Type (2020 and 2028)
8.3 Monoclonal Antibodies
8.3.1 Overview
8.3.2 Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Polyclonal Antibodies
8.4.1 Overview
8.4.2 Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
8.5 Other Custom Antibodies
8.5.1 Overview
8.5.2 Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
9. Europe Custom Antibody Market Analysis and Forecasts To 2028 – By Source
9.1 Overview
9.2 Custom Antibody Market Revenue Share, By Source (2020 and 2028)
9.3 Mice
9.3.1 Overview
9.3.2 Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Rabbit
9.4.1 Overview
9.4.2 Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Custom Antibody Market Analysis and Forecasts to 2028– By Research Area
10.1 Overview
10.2 Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Immunology
10.4.1 Overview
10.4.2 Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Stem Cells
10.5.1 Overview
10.5.2 Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Infectious Disease
10.6.1 Overview
10.6.2 Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.7 Neurobiology
10.7.1 Overview
10.7.2 Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.8 Cardiovascular Disease
10.8.1 Overview
10.8.2 Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
10.9 Others
10.9.1 Overview
10.9.2 Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
11. Europe Custom Antibody Market Analysis and Forecasts to 2028– By End User
11.1 Overview
11.2 Custom Antibody Market Revenue Share, by End User (2020 and 2028)
11.3 Pharmaceutical and Biotechnology Companies
11.3.1 Overview
11.3.2 Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.4 Academic and Research Institutes
11.4.1 Overview
11.4.2 Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
11.5 Contract Research Organizations
11.5.1 Overview
11.5.2 Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
12. Custom Antibody Market Revenue and Forecasts to 2028 – Geographical Analysis
12.1 Europe: Custom Antibody Market
12.1.1 Overview
12.1.2 Europe: Custom Antibody Market, by Country, 2020 & 2028 (%)
12.1.2.1 UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.1 UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.1.2 UK: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.1.3 UK: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.1.4 UK: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.1.5 UK: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.1.6 UK: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.2 Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.1 Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.2.2 Germany: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.2.3 Germany: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.2.4 Germany: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.2.5 Germany: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.2.6 Germany: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.3 France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.1 France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.3.2 France: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.3.3 France: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.3.4 France: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.3.5 France: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.3.6 France: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.4 Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.1 Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.4.2 Italy: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.4.3 Italy: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.4.4 Italy: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.4.5 Italy: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.4.6 Italy: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.5 Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.1 Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.5.2 Spain: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.5.3 Spain: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.5.4 Spain: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.5.5 Spain: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.5.6 Spain: Custom Antibody Market, by End User, 2019–2028 (USD Million)
12.1.2.6 Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.1 Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
12.1.2.6.2 Rest of Europe: Custom Antibody Market, by Service, 2019–2028 (USD Million)
12.1.2.6.3 Rest of Europe: Custom Antibody Market, by Type, 2019–2028 (USD Million)
12.1.2.6.4 Rest of Europe: Custom Antibody Market, by Source, 2019–2028 (USD Million)
12.1.2.6.5 Rest of Europe: Custom Antibody Market, by Research Area, 2019–2028 (USD Million)
12.1.2.6.6 Rest of Europe: Custom Antibody Market, by End User, 2019–2028 (USD Million)
13. Impact Of COVID-19 Pandemic on Europe Custom Antibody Market
13.1 Europe: Impact Assessment of COVID-19 Pandemic
14. Industry Landscape
14.1 Overview
14.2 Growth Strategies Done by the Companies in the Market, (%)
14.3 Inorganic Growth Strategies
14.3.1 Overview
14.4 Organic Growth Strategies
14.4.1 Overview
15. COMPANY PROFILES
15.1 THERMO FISHER SCIENTIFIC INC.
15.1.1 Key Facts
15.1.2 Business Description
15.1.3 Products and Services
15.1.4 Financial Overview
15.1.5 SWOT Analysis
15.1.6 Key Developments
15.2 BIO-RAD LABORATORIES INC.
15.2.1 Key Facts
15.2.2 Business Description
15.2.3 Products and Services
15.2.4 Financial Overview
15.2.5 SWOT Analysis
15.2.6 Key Developments
15.3 MERCK KGaA
15.3.1 Key Facts
15.3.2 Business Description
15.3.3 Products and Services
15.3.4 Financial Overview
15.3.5 SWOT Analysis
15.3.6 Key Developments
15.4 ABCAM
15.4.1 Key Facts
15.4.2 Business Description
15.4.3 Products and Services
15.4.4 Financial Overview
15.4.5 SWOT Analysis
15.4.6 Key Developments
15.5 GenScript
15.5.1 Key Facts
15.5.2 Business Description
15.5.3 Products and Services
15.5.4 Financial Overview
15.5.5 SWOT Analysis
15.5.6 Key Developments
15.6 Agilent Technologies, Inc.
15.6.1 Key Facts
15.6.2 Business Description
15.6.3 Products and Services
15.6.4 Financial Overview
15.6.5 SWOT Analysis
15.6.6 Key Developments
15.7 Cell Signaling Technology, Inc.
15.7.1 Key Facts
15.7.2 Business Description
15.7.3 Products and Services
15.7.4 Financial Overview
15.7.5 SWOT Analysis
15.7.6 Key Developments
16. Appendix
16.1 About the Insight Partners
16.2 Glossary of Terms
LIST OF TABLES
Table 1. UK: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 2. UK: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 3. UK: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 4. UK: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 5. UK: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. Germany: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 7. Germany: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Germany: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 9. Germany: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 10. Germany: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 11. France: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 12. France: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 13. France: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 14. France: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 15. France: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 16. Italy: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 17. Italy: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Italy: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 19. Italy: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 20. Italy: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 21. Spain: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 22. Spain: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Spain: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 24. Spain: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 25. Spain: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 26. Rest of Europe: Custom Antibody Market, by Service – Revenue and Forecast to 2028 (USD Million)
Table 27. Rest of Europe: Custom Antibody Market, by Type – Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe: Custom Antibody Market, by Source– Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Europe: Custom Antibody Market, by Research Area– Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Europe: Custom Antibody Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 31. Recent Inorganic Growth Strategies in the Custom Antibody Market
Table 32. Recent Organic Growth Strategies in the Custom Antibody Market
Table 33. Glossary of Terms, Custom Antibody Market
LIST OF FIGURES
Figure 1. Custom Antibody Market Segmentation
Figure 2. Europe Custom Antibody Market Overview
Figure 3. Antibody Development Segment Held Largest Share of Service in Custom Antibody Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Custom Antibody Market - Europe PEST Analysis
Figure 6. Custom Antibody Market Impact Analysis of Driver and Restraints
Figure 7. Europe Custom Antibody Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Custom Antibody Market Revenue Share, by Service (2020 and 2028)
Figure 9. Antibody Development: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 10. Antibody Production and Purification: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11. Antibody Fragmentation and Labelling: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Custom Antibody Market Revenue Share, by Type (2020 and 2028)
Figure 13. Monoclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Polyclonal Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Other Custom Antibodies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16. Custom Antibody Market Revenue Share, by Source (2020 and 2028)
Figure 17. Mice: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Rabbit: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Custom Antibody Market Revenue Share, by Research Area (2020 and 2028)
Figure 21. Oncology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Immunology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Stem Cells: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Infectious Disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Neurobiology: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Cardiovascular disease: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Custom Antibody Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Custom Antibody Market Revenue Share, by End User (2020 and 2028)
Figure 29. Pharmaceutical and Biotechnology Companies: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. Academic and Research Institutes: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Contract Research Organizations: Custom Antibody Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Europe: Custom Antibody Market, by Key Country – Revenue (2020) (USD Million)
Figure 33. Europe: Custom Antibody Market , by Country, 2020 & 2028 (%)
Figure 34. UK: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. Germany: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. France: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Italy: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 38. Spain: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 39. Rest of Europe: Custom Antibody Market – Revenue and Forecast to 2028 (USD Million)
Figure 40. Impact of COVID-19 Pandemic in European Country Markets
Figure 41. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc.
- Merck KGAA
- Abcam
- Genscript
- Agilent Technologies, Inc.
- Cell Signaling Technology, Inc.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Europe Custom Antibody Market
Jul 2021
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2021
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Jul 2021
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Jul 2021
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Jul 2021
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)